Immunosenescent T-cell proportion

1. Combination antiretroviral therapy is associated with immunosenescent T-cell proportion in humans (23% (6-80) versus 28% (4-52)).

   “The proportion of immunosenescent T cells (CD8+CD28−CD57+KLRG1+) was lower in the ART+ group [23% (6-80)] than in the ART- group [28% (4-52)].”

   HumansHIV-1 infection; treated versus treatment-naïve individualsT cellprolonged

   Immunosenescence and immune dysfunction in treated and untreated HIV-infected individuals

   The Indian journal of medical research·1 Aug 2026

More on Combination antiretroviral therapy